Irvine Pharmaceutical Services Brings Avrio Parenteral Manufacturing Facility Under Irvine Brand

Irvine Pharmaceutical Services announced recently that it is incorporating its Avrio parenteral manufacturing facility into the Irvine brand. The move was made to better communicate the breadth of Irvine’s services and to streamline processes for clients, Marketing Vice President Eric Hoffman explained.

The custom-built parenteral manufacturing facility includes three cGMP manufacturing suites, and a formulation lab and pilot suite, all designed to optimize customer convenience, manufacturing excellence, and quality control. Features include passive restrictive access barrier system (RABS) for filling; dedicated air-handling in each suite, and recording video devices so clients may view product development in real time.

“In addition to our 25-year history providing analytical CMC support, our offering of parenteral manufacturing services completes a seamless outsourcing solution for our pharmaceutical drug and device clients.”  Hoffman said. The Irvine campus, made up of three facilities totals more than 75,000 square feet of cGMP laboratories and manufacturing space.

About Irvine
Irvine Pharmaceutical Service Inc. is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Irvine provides full cGMP specialized product development service such as preformulation/formulation, analytical development, parenteral manufacturing, stability storage and complete analytical CMC testing. For more information, visit www.irvinepharma.com